Is endotoxin receptor CD14 rs2569190/C-159T gene correlated with chronic hepatitis C?

Aug 26, 2009

It is still unknown why the natural history of chronic disease caused by hepatitis C virus (HCV), which currently infects 3% of the world's population, varies from mild in some patients to rapidly progressing in others.

Age, sex, alcohol consumption and liver sensitivity to gut-derived bacterial endotoxins, were the early factors defined to enhance the risk of fibrosis progression. Host genetic variations, e.g., the CD14 single nucleotide polymorphism (SNP), rs2569190/C-159T, have been recently intensively investigated and suggested to be prognostic factors for cirrhosis in various liver diseases. Is this endotoxin receptor SNP correlated with liver disease features in patients?

A research article to be published on August 21, 2009 in the addresses this question. The research team lead by Professor Sabine Mihm and her colleagues from the Department of Gastroenterology and Endocrinology, University Medical Center Göttingen, Germany, analyzed the distribution of various epidemiological, biochemical, and histological characteristics in 2 cohorts of Caucasian chronic hepatitis C patients with respect to their genotypes according to the CD14 rs2569190/C-159T SNP.

In one cohort, patients who carried 2 variant alleles (TT) were found to be younger than C allele carriers (CC or CT). Among the histological lesions studied, portal lymphoid aggregates were more frequently observed among TT than among C carriers. The presence of portal lymphoid aggregates was also closely correlated with another 2 lesions, moderate and severe hepatic inflammation and the presence of bile duct damage. However, the degree of fibrosis was not found to be related to the CD14 gene C-159T SNP.

The different situation between chronic liver diseases caused by HCV infection or by in relation to TT status suggests that endotoxin sensitivity depends on both genetic and environmental factors (gene environment interaction). Our analysis suggests, for the first time, a relationship between the CD14 variation and the formation of portal lymphoid aggregates, which was attributed to the host's immunological participation in liver disease pathogenesis.

More information: Askar E, Ramadori G, Mihm S. Endotoxin receptor CD14 genevariants and histological features in chronic HCV infection. World J Gastroenterol 2009; 15(31): 3884-3890 www.wjgnet.com/1007-9327/15/3884.asp

Source: World Journal of Gastroenterology (news : web)

Explore further: Fecal microbiota transplant cures C. diff, blocks multi-drug resistant pathogens

Related Stories

Recommended for you

Scientists reverse bacterial resistance to antibiotics

9 hours ago

The rise of antibiotic-resistant bacteria is a growing problem in the United States and the world. New findings by researchers in evolutionary biology and mathematics could help doctors better address the ...

Plant toxin causes biliary atresia in animal model

9 hours ago

A study in this week's Science Translational Medicine is a classic example of how seemingly unlikely collaborators can come together to make surprising discoveries. An international team of gastroenterologists, pediat ...

Statins don't reduce psoriasis risk

10 hours ago

(HealthDay)—Statin use does not lower the risk of psoriasis, according to a study published online April 20 in the British Journal of Dermatology.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.